Coronavirus-Like Particle COVID-19 Vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Jul 10, 2020 (NCT04450004)
Timeline
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, active
immunity, active - SARS-CoV-2
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04636697 | Phase 2/Phase 3 (Phase 3) | Nov 19, 2020 | Medicago |
| NCT04450004 | Phase 1 | Jul 10, 2020 | Medicago |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medicago | For profit | 2 | 2 | 2 | 2020 |
1 organizations
Page 1 / 1